FABP1 and metabolic dysfunction-associated steatotic liver disease: To investigate the impact of FABP1 plasma level on anthropometric and clinical laboratory parameters and overt NAFLD, we divided the patients into three groups according to the tertiles of sex-specific FABP1 plasma level.